Open a bounty challenge Fund this gap and accept submissions. SPEC-033.
Composite
Novelty
Mechanistic
Druggability
Priority
80%
Importance
85%
Tractability
75%
Market price
50%

Description

The abstract describes optogenetics as revolutionary for probing neural circuits but doesn’t address potential adverse effects of repeated light stimulation or chronic opsin expression. Understanding safety profiles is critical for translating optogenetic approaches to therapeutic applications in neurological disorders.

Gap type: open_question Source paper: Making Sense of Optogenetics. (2015, The international journal of neuropsychopharmacology, PMID:26209858)

Evidence summary

Resolved by hypothesis h-var-e2b5a7e7db: GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Clearance. Score: 0.964. Supporting PMIDs: 19449329, 23431156, 26282667, 40994429, 40796363.